Alerts will be sent to your verified email
Verify Email
VINEETLAB
|
Vineet Laboratories
|
Medicamen Organics
|
Kabra Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.26 % | 7.97 % | 65.41 % |
|
5yr average Equity Multiplier
|
3.18 | 3.29 | -11.28 |
|
5yr Average Asset Turnover Ratio
|
1.36 | 0.76 | 0.0 |
|
5yr Avg Net Profit Margin
|
1.11 % | 3.89 % | 0.0 |
|
Price to Book
|
2.82 | 0.0 | 1.62 |
|
P/E
|
0.0 | 11.89 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
89.15 Days | -32.99 Days | 0.0 |
|
Inventory Days
|
66.38 Days | 70.3 Days | 0.0 |
|
Days Receivable
|
80.91 Days | 198.36 Days | 0.0 |
|
Days Payable
|
81.06 Days | 321.34 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
2.14 | 3.25 | -836.53 |
|
5yr Avg ROCE
|
14.46 % | 15.06 % | 64.57 % |
|
5yr Avg Operating Profit Margin
|
3.72 % | 9.86 % | 0.0 |
|
5 yr average Debt to Equity
|
0.69 | 1.18 | -6.16 |
|
5yr CAGR Net Profit
|
n/a | 51.57 % | 65.28 % |
|
5yr Average Return on Assets
|
1.2 % | 2.68 % | -21.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
29.26 % | 59.73 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-6.7 % | 0.04 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vineet Laboratories
|
Medicamen Organics
|
Kabra Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|